Translational Biomarkers Conference September 7, 2011

Presented by Cambridge Healthtech Institute, the inaugural Translational Biomarkers Conference will be part of the third annual Accelerating Development and Advancing Personalized Therapy (ADAPT) Congress. The conference will focus on the use of biomarkers to indicate an effective treatment or cure and new initiatives from regulators to have biomarker assays available as drugs are developed,. The event will additionally showcase the latest in translatable biomarkers (pharmacodynamic, predictive, prognostic, toxicological and diagnostic), animal models, and their use for direct prediction in man.

Jiaqi Huang will be speaking on "Altered Expression of Insulin Receptor Isoforms in Breast Cancer." MedImmune is a sponsor.